3-{[(5-Benzyl-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide

ID: ALA2443197

PubChem CID: 136219395

Max Phase: Preclinical

Molecular Formula: C20H19N3O4S2

Molecular Weight: 429.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nc(SCC(=O)c2cccc(S(N)(=O)=O)c2)[nH]c(=O)c1Cc1ccccc1

Standard InChI:  InChI=1S/C20H19N3O4S2/c1-13-17(10-14-6-3-2-4-7-14)19(25)23-20(22-13)28-12-18(24)15-8-5-9-16(11-15)29(21,26)27/h2-9,11H,10,12H2,1H3,(H2,21,26,27)(H,22,23,25)

Standard InChI Key:  RZGJOMPTDIVYQA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   22.9413   -9.4623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1163   -9.4623    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.5288  -10.1768    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4066   -7.3998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4054   -8.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1202   -8.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8366   -8.2267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8338   -7.3962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1184   -6.9871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5467   -6.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2627   -7.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5436   -6.1561    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.9756   -6.9756    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.6916   -7.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6916   -8.2093    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4067   -8.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1207   -8.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1148   -7.3745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3991   -6.9685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4055   -9.8773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.8262   -6.9568    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.8371   -8.6126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4094   -9.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5496   -8.1964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2649   -8.6078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9769   -8.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9730   -7.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2515   -6.9579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5426   -7.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 14  1  0
  6  2  1  0
  2 20  1  0
 18 21  2  0
 17 22  1  0
 16 23  1  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2443197

    ---

Associated Targets(Human)

CA13 Tclin Carbonic anhydrase XIII (905 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA7 Tclin Carbonic anhydrase VII (2318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA6 Tclin Carbonic anhydrase VI (993 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 429.52Molecular Weight (Monoisotopic): 429.0817AlogP: 2.29#Rotatable Bonds: 7
Polar Surface Area: 122.98Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 7.64CX Basic pKa: CX LogP: 2.57CX LogD: 2.40
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.34Np Likeness Score: -1.85

References

1. Čapkauskaitė E, Zubrienė A, Smirnov A, Torresan J, Kišonaitė M, Kazokaitė J, Gylytė J, Michailovienė V, Jogaitė V, Manakova E, Gražulis S, Tumkevičius S, Matulis D..  (2013)  Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.,  21  (22): [PMID:24103428] [10.1016/j.bmc.2013.09.029]

Source